Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 408 | 423 | 364 | 188 | 66 |
| Other Working Capital | 5 | 80 | -67 | -103 | 550 |
| Other Operating Activity | -1,206 | -1,034 | -775 | -383 | -1,089 |
| Operating Cash Flow | $-793 | $-531 | $-478 | $-298 | $-473 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -993 | -854 | -690 | -690 | -690 |
| Other Investing Activity | 41,240 | 31,457 | 22,361 | 182 | 1,337 |
| Investing Cash Flow | $40,247 | $30,603 | $21,671 | $-508 | $647 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,327 | 1,167 | 962 | 862 | 690 |
| Debt Repayment | -65 | -65 | -65 | -65 | N/A |
| Common Stock Repurchased | -40,727 | -30,991 | -22,099 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -8 |
| Financing Cash Flow | $-39,465 | $-29,889 | $-21,202 | $797 | $683 |
| Beginning Cash Position | 11 | 11 | 11 | 11 | 449 |
| End Cash Position | 0 | 194 | 1 | 2 | 11 |
| Net Cash Flow | $-11 | $183 | $-10 | $-9 | $-438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -793 | -531 | -478 | -298 | -473 |
| Free Cash Flow | -793 | -531 | -478 | -298 | -473 |